Thai-developed vaccine set to proceed to human trials
Up 5m doses of ‘ChulaCov19’ can be produced by year-end
Thailand’s second domestically developed vaccine will soon undergo human trials, officials said on Thursday, adding that the plan was to produce up to 5 million doses by the end of the year.
The mRNA vaccine, developed by Chulalongkorn University, had success in trials in mice and monkeys and is due to be tested on humans in late April or early May, Kiat Ruxrungtham of the Chula Vaccine Research Center said.
“By year-end, we should have a…
